Saturday, December 4, 2021  | 28 Rabiulakhir, 1443
Samaa TV
Facebook Twitter Youtube
HOME > News

India first priority for AstraZeneca/Oxford vaccine delivery: Serum Institute

Oxford says its COVID-19 vaccine is 70% effective

SAMAA | - Posted: Nov 24, 2020 | Last Updated: 1 year ago
Posted: Nov 24, 2020 | Last Updated: 1 year ago

India’s biggest syringe manufacturer is ramping up its production to churn out 1 billion units. Photo: AFP

India will be given first priority for the delivery of the AstraZeneca/Oxford vaccine after its British developers claimed success following mass testing, the world’s largest vaccine manufacturer by volume said Monday.

The chief executive of the Serum Institute of India, Adar Poonawalla, said the manufacturer has already produced 40 million doses of the vaccine so far.

“By January, we should have, you know, 100 million doses is minimum because we’ve already made 40 million doses,” Poonawalla, whose father founded the vaccine manufacturer, told television broadcaster NDTV.

Poonawalla said he expected that some 90% of Serum Institute’s doses were to be sold to the Indian government at around 250 rupees (US$3.00).

“Most of that 90% is what’s going to go to the government of India and maybe 10% in the private market at the higher price (of 1,000 rupees),” he said.

“We’re hoping for this emergency use licence so that by the end of December, January we can start rolling out some (doses).”

AstraZeneca and Oxford University said Monday that their drug had proved on average 70% effective at stopping the virus after trying it on 23,000 people.

The Oxford drug can be transported easily at normal refrigerator temperatures, unlike some of the other candidates, which require extremely cold storage.

AstraZeneca said it planned to produce up to three billion doses of the vaccine in 2021 if it passes the remaining regulatory hurdles.

The Serum Institute in August struck a deal with Gavi, the Vaccine Alliance, to produce up to 100 million COVID-19 doses of two different potential vaccines from AstraZeneca and US biotech company Novavax.

Once the vaccines gain regulatory approval, the doses could be produced as early as the first half of 2021 for distribution to low- and middle-income countries, Gavi said.

India’s Health Minister Harsh Vardhan told India Today TV earlier Monday that he expected between 250-300 million Indians would be immunised by September next year.

First in line would be health workers, other frontline workers including the police, paramilitary and those working in sanitisation, as well as people aged above 65, Vardhan added.

Prime Minister Narendra Modi is expected to meet with state leaders on Tuesday for discussions about the distribution of the vaccine, local media reported.

India is the second worst-infected nation after the United States with more than 9.1 million virus cases.

FaceBook WhatsApp

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp

india corona situation, india corona situation news today, oxford corona vaccine, coronavirus vaccine news

Karachi’s first winter spell to hit after December 6
NAB arrests Sindh Assembly speaker Agha Siraj Durrani
Pakistan Embassy Serbia’s Twitter ‘hacked from Karachi’
Philippine national found dead on ship at Port Qasim
Imran wants PAC to expose his government’s corruption as well
PM, COAS condemn Sialkot lynching as Sri Lanka demands probe
Islamabad bound flight survives bird strike
President Alvi signs EVMs bill into law
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp